According to a previous study, quercetin inhibited tumor growth in prostate cancer by targeting the angiogenic pathway which mediated by VEGFR-2 and as a result inhibiting the expression of the AKT/mTOR/ribosomal protein S6 kinase (P70S6K) regulatory factor (17). Here, KDR is linked to neoplasm.